Anti-inflammatory effect of suplatast tosilate on mild asthma.
Sano
Y
Y
Miyamoto
T
T
Makino
S
S
D000328:Adult; D000368:Aged; D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001190:Arylsulfonates / Q000008:administration & dosage / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001985:Bronchial Provocation Tests; D002214:Capsules; D002465:Cell Movement / Q000187:drug effects; D004804:Eosinophils / Q000187:drug effects; D005541:Forced Expiratory Volume / Q000187:drug effects; D006633:Histamine Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007073:Immunoglobulin E / Q000187:drug effects; D015847:Interleukin-4 / Q000037:antagonists & inhibitors; D015848:Interleukin-5 / Q000037:antagonists & inhibitors; D008875:Middle Aged; D013183:Sputum / Q000166:cytology / Q000187:drug effects; D013452:Sulfonium Compounds / Q000008:administration & dosage / Q000627:therapeutic use*
D018926:Anti-Allergic Agents; D000893:Anti-Inflammatory Agents; D001190:Arylsulfonates; D002214:Capsules; D006633:Histamine Antagonists; D015848:Interleukin-5; D013452:Sulfonium Compounds; D015847:Interleukin-4; D007073:Immunoglobulin E; C073028:suplatast tosilate